Please login to the form below

Not currently logged in
Email:
Password:

GERD

This page shows the latest GERD news and features for those working in and with pharma, biotech and healthcare.

Teva’s generic Nexium wins US approval

Teva’s generic Nexium wins US approval

GERD is a serious form of gastroesophageal reflux, whereby a person's stomach contents come back into the oesophagus. ... This can cause acid indigestion, more commonly known as heartburn. Gastroesophageal reflux is definited as GERD when it occurs more

Latest news

  • AZ advances immuno-oncology ambitions AZ advances immuno-oncology ambitions

    MedImmune - AZ's biologics division - will take full control of Definiens and its technologies, including its Cognition Network Technology, developed by Nobel Laureate Prof Gerd Binnig.

  • Takeda launches mobile app for heartburn patients Takeda launches mobile app for heartburn patients

    Food4GERD app includes symptom tracker and ingredient check functions. Takeda has launched a new mobile app to help patients with gastroesophageal reflux disease (GERD), or heartburn, manage their symptoms.

  • AstraZeneca launches Nexium YouTube channel

    With more than one billion unique users visiting YouTube each month, the Nexium YouTube channel puts everything from background on GERD to information on cost savings for Nexium at patients' fingertips.". ... The AZPurpleZone channel includes:. 'Burning

  • Comment: AstraZeneca's branded approach to YouTube Comment: AstraZeneca's branded approach to YouTube

    AstraZeneca has launched a branded YouTube channel to promote its blockbuster gastroesophageal reflux disease (GERD) treatment Nexium (esomprazole). ... Although its first videos are Nexium adverts, AZ plans a regular, weekly series of “Burning

  • Omnicom to enhance German presence

    Led by founders Dr Gerd Wirtz and Anett Coerper, has created a remarkable business which is both creative and innovative and unique in the healthcare agency space.

More from news
Approximately 1 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • Communicating health messages Communicating health messages

    Consider a 2010 study by Gerd Gigerenzer of the Harding Center for Risk Literacy.

  • The rise of chronic disease in BRIC markets The rise of chronic disease in BRIC markets

    29 per cent report gastrointestinal conditions such as gastroesophageal reflux disease (GERD), IBS and diverticulitis.

  • Pharma deals during October 2012 Pharma deals during October 2012

    As a further dimension to their relationship, the companies also announced a co-promotion agreement in the US for AZ's Nexium (esomeprazole magnesium) for gastroesophageal reflux disease (GERD). ... Many patients with IBS-C also suffer from GERD so this

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • GlycoVaxyn appoints Gerd Zettlmeissl as chairman GlycoVaxyn appoints Gerd Zettlmeissl as chairman

    He will join the Swiss vaccines company in June. Swiss vaccines company GlycoVaxyn has appointed Gerd Zettlmeissl as chairman of the board of directors with effect from June, when he will ... Having chaired the board for more than seven years, I will

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....